EGX disclosure regarding the upcoming OGM on 25 March 2020 Regulatory DisclosuresBy adminMarch 1, 2020
Details Board of Directors Report on 17 February 2020Board and Shareholders ActionsBy adminFebruary 18, 2020
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Reports double-digit topline growth in FY19 and major facility upgrades & expansions completed during the year Corporate NewsBy adminFebruary 18, 2020
Details Standalone financial statements for the period ended 31 December 2019By adminFebruary 18, 2020
Details Consolidated financial statements for the period ended 31 December 2019Consolidated Financial Statements resultsBy adminFebruary 18, 2020
Details BOD Meeting Minutes on 17 February 2020Board and Shareholders ActionsBy adminFebruary 17, 2020
